XML 54 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
9 Months Ended
Sep. 30, 2014
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
Note 8. Stock-Based Compensation

We account for stock-based compensation in accordance with the provisions of FASB Accounting Standards Codification (“ASC”) topic 718, Compensation-Stock Compensation (“ASC 718”), which established accounting for stock-based awards exchanged for employee services. Stock-based compensation cost is measured at each grant date, based on the fair value of the award, and is recognized as expense over the employee’s requisite service period of the award. All of our stock-based compensation is accounted for as an equity instrument.

The following table summarizes compensation costs related to our stock-based awards (in thousands):

  
Three Months Ended
September 30,
  
Nine Months Ended
September 30,
 
  
2014
  
2013
  
2014
  
2013
 
         
Cost of revenue
 
$
4
  
$
6
  
$
14
  
$
17
 
Selling, general and administrative
  
227
   
285
   
716
   
860
 
Research and development
  
41
   
43
   
131
   
127
 
Total stock-based compensation
  
272
   
334
   
861
   
1,004
 
Tax effect on stock-based compensation
  
   
   
   
 
Net effect on net income (loss)
 
$
272
  
$
334
  
$
861
  
$
1,004
 

As of September 30, 2014, the unamortized compensation costs related to unvested stock options granted to employees under our stock option plan was approximately $1.3 million, net of estimated forfeitures of $46,000. These costs will be amortized on a straight-line basis over a weighted-average period of approximately 2.6 years and will be adjusted for subsequent changes in estimated forfeitures. We elected not to capitalize any stock-based compensation to inventory as of September 30, 2014 due to the immateriality of the amount.
 
We estimate the fair value of stock options using the Black-Scholes valuation model. There were 200,000 and 60,000 stock options granted with weighted average grant date fair values of $1.08 and $1.21 in the three months ended September 30, 2014 and 2013, respectively. There were 252,000 and 60,000 stock options granted with weighted average grant date fair values of $1.09 and $1.21 in the nine months ended September 30, 2014 and 2013, respectively. The fair value of our stock options granted to employees for the three and nine months ended September 30, 2014 was estimated using the following weighted-average assumptions:

  
Three Months Ended
  
Nine Months Ended
 
  
September 30, 2014
  
September 30, 2014
 
     
Expected term (in years)
  
4.4
   
4.3
 
Volatility
  
62.26
%
  
63.10
%
Expected dividend
  
0
%
  
0
%
Risk-free interest rate
  
1.86
%
  
1.88
%
 
The following table summarizes the stock option transactions during the nine months ended September 30, 2014 (in thousands, except per share data):

Stock Options
 
Shares
  
Weighted-
average
Exercise
Price
  
Weighted-
average
Remaining
Contractual
Life
(in years)
  
Aggregate
Intrinsic
Value
 
         
Balance as of January 1, 2014
  
2,671
  
$
3.29
   
6.71
  
$
893
 
Granted
  
252
   
2.26
         
Exercised
  
(112
)
  
1.21
         
Canceled and expired
  
(73
)
  
5.18
         
Balance as of September 30, 2014
  
2,738
  
$
3.23
   
6.72
  
$
585
 
                 
Options vested and expected to vest as of September 30, 2014
  
2,738
  
$
3.23
   
6.72
  
$
585
 
                 
Options exercisable as of September 30, 2014
  
1,688
  
$
3.52
   
5.44
  
$
505
 

The aggregate intrinsic value in the table above represents the total pretax intrinsic value, based on our closing price of $2.44 on September 30, 2014, which would have been received by the option holder had all option holders exercised their options on that date.

Restricted stock awards

A summary of activity related to restricted stock awards for the nine months ended September 30, 2014 is presented below:

Stock Awards
 
Shares
  
Weighted-Average
Grant Date Fair Value
 
Non-vested as of January 1, 2014
  
241,232
  
$
3.44
 
Granted
  
55,044
  
$
2.18
 
Vested
  
(48,420
)
 
$
4.66
 
Non-vested as of September 30, 2014
  
247,856
  
$
2.92
 

As of September 30, 2014, the unamortized compensation costs related to unvested restricted stock awards was approximately $514,000, which is to be amortized on a straight-line basis over a weighted average period of approximately 1.2 years.